These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33521063)

  • 21. ECG Changes during Adult Life in Fabry Disease: Results from a Large Longitudinal Cohort Study.
    El Sayed M; Postema PG; Datema M; van Dussen L; Kors JA; Ter Haar CC; Bleijendaal H; Galenkamp H; van den Born BH; Hollak CEM; Langeveld M
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766461
    [No Abstract]   [Full Text] [Related]  

  • 22. ECG low QRS voltage and wide QRS complex predictive of centenarian 360-day mortality.
    Szewieczek J; Gąsior Z; Duława J; Francuz T; Legierska K; Batko-Szwaczka A; Hornik B; Janusz-Jenczeń M; Włodarczyk I; Wilczyński K
    Age (Dordr); 2016 Apr; 38(2):44. PubMed ID: 27039197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic Left Ventricular Hypertrophy Is Independently Associated With Better Long-Term Outcomes in Dilated Cardiomyopathy Patients.
    Matsushima S; Kaku H; Enzan N; Ide T; Higo T; Tsuchihashi-Makaya M; Tsutsui H
    Circ Rep; 2019 May; 1(6):248-254. PubMed ID: 33693146
    [No Abstract]   [Full Text] [Related]  

  • 24. Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population.
    Leng YLY; Zhou Y; Ke H; Jelinek H; McCabe J; Assareh H; McLachlan CS
    Medicine (Baltimore); 2015 Jul; 94(27):e1080. PubMed ID: 26166085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiogram sensitivity in left ventricular hypertrophy according to gender and cardiac mass.
    Colossimo AP; Costa Fde A; Riera AR; Bombig MT; Lima VC; Fonseca FA; Izar MC; L Filho B; Souza D; Povoa RM
    Arq Bras Cardiol; 2011 Sep; 97(3):225-31. PubMed ID: 21845342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prolonged corrected QT interval is predictive of future stroke events even in subjects without ECG-diagnosed left ventricular hypertrophy.
    Ishikawa J; Ishikawa S; Kario K
    Hypertension; 2015 Mar; 65(3):554-60. PubMed ID: 25534703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrocardiographic characteristics and metabolic risk factors associated with inappropriately high left ventricular mass in patients with electrocardiographic left ventricular hypertrophy: the LIFE Study.
    Palmieri V; Okin PM; de Simone G; Bella JN; Wachtell K; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
    J Hypertens; 2007 May; 25(5):1079-85. PubMed ID: 17414673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Electrocardiogram Is a Poor Diagnostic Tool to Detect Left Ventricular Hypertrophy in Children: A Comparison with Echocardiographic Assessment of Left Ventricular Mass.
    Bratincsák A; Williams M; Kimata C; Perry JC
    Congenit Heart Dis; 2015; 10(4):E164-71. PubMed ID: 25600360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM; Boman K; Gohlke-Baerwolf C; Kesäniemi YA; Nienaber C; Ray S; Egstrup K; Rossebø AB; Devereux RB; Køber L; Willenheimer R; Wachtell K
    Circulation; 2012 Jan; 125(2):346-53. PubMed ID: 22147903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular mass and hypertrophy assessment by means of the QRS complex voltage-independent measurements.
    Sosnowski M; Korzeniowska B; Tendera M
    Int J Cardiol; 2006 Jan; 106(3):382-9. PubMed ID: 15996771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis.
    Beck M; Hughes D; Kampmann C; Larroque S; Mehta A; Pintos-Morell G; Ramaswami U; West M; Wijatyk A; Giugliani R;
    Mol Genet Metab Rep; 2015 Jun; 3():21-7. PubMed ID: 26937390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy.
    Schmied C; Nowak A; Gruner C; Olinger E; Debaix H; Brauchlin A; Frank M; Reidt S; Monney P; Barbey F; Shah D; Namdar M
    Heart; 2016 Aug; 102(16):1309-14. PubMed ID: 27056970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of conduction velocity slowing in left ventricular midwall on the QRS complex morphology: A simulation study.
    Bacharova L; Szathmary V; Svehlikova J; Mateasik A; Gyhagen J; Tysler M
    J Electrocardiol; 2016; 49(2):164-70. PubMed ID: 26803553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QRS complex waveform indicators of ventricular activation slowing: Simulation studies.
    Bacharova L; Szathmary V; Svehlikova J; Mateasik A; Tysler M
    J Electrocardiol; 2016; 49(6):790-793. PubMed ID: 27554423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia--its influence on diagnosis, triage, and short-term prognosis: a multicenter study.
    Larsen GC; Griffith JL; Beshansky JR; D'Agostino RB; Selker HP
    J Gen Intern Med; 1994 Dec; 9(12):666-73. PubMed ID: 7876948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early cardiac changes in children with anderson-fabry disease.
    Havranek S; Linhart A; Urbanova Z; Ramaswami U
    JIMD Rep; 2013; 11():53-64. PubMed ID: 23546814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of agalsidase alfa replacement therapy on Fabry disease-related hypertrophic cardiomyopathy: a 12- to 36-month, retrospective, blinded echocardiographic pooled analysis.
    Kampmann C; Linhart A; Devereux RB; Schiffmann R
    Clin Ther; 2009 Sep; 31(9):1966-76. PubMed ID: 19843486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    J Electrocardiol; 1996; 29 Suppl():256-61. PubMed ID: 9238409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and effectiveness of enzyme replacement therapy with agalsidase alfa in patients with Fabry disease: Post-marketing surveillance in Japan.
    Sasa H; Nagao M; Kino K
    Mol Genet Metab; 2019 Apr; 126(4):448-459. PubMed ID: 30803893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.